GeoVax
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1955 Lake Park Dr SE Ste 300, Smyrna, Ge...Phone Number
(678) 384-7220Website
www.geovax.comRevenue
<$5 MillionStock Symbol
GOVXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GeoVax
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer using novel proprietary platforms. GeoVax's product pipeline includes two ongoing Phase 2 clinical trials of GEO-CM04S1 (formerly COH04S1) for COVID-19 as a universal booster vaccine to mRNA vaccines authorized by the U.S. Food and Drug Administration (FDA) and as a primary vaccine for use in immunocompromised patients.Explore more
GeoVax Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GeoVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
GeoVax, which may be a good buyer, showed buying intent in Masked Content Topic
Check if GeoVax has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GeoVax
Click to see if GeoVax had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once GeoVax has new funding data
Earning: See what the market has to say on GeoVax recently announced quarterly report
Check out if GeoVax is spiking on competitors!
Product Launch: Get notified when GeoVax launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at GeoVax
Find 2 more new buyers
Compare Similar Companies to GeoVax
Compare insights from companies similar to GeoVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GeoVax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GeoVax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GeoVax.
GeoVax financials insights
Gather financial insights about GeoVax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2026
Stock/Share Issuance
$2.7M
GeoVax Tech Stack
A closer look at the technologies used by GeoVax
Most Recent Scoops
Funding
Funding
Person-Based
Person-Based
Person-Based
Person-Based
GeoVax News & Media
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
ATLANTA, GA - December 19, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into definit...GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript
GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsDavid Dodd - Chairman, President & CEOMark Reynolds -...GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript
GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2025 Earnings Conference Call July 28, 2025 4:30 PM ETCompany ParticipantsDavid Alan Dodd - Chairman, President &...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeoVax
Sign Up For FreeTo access detailed company insights
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer using novel proprietary platforms. GeoVax's product pipeline includes two ongoing Phase 2 clinical trials of GEO-CM04S1 (formerly COH04S1) for COVID-19 as a universal booster vaccine to mRNA vaccines autho... Read More
